ACTRN12607000274471
Completed
未知
The effectiveness of a primary care disease detection program in the identification of Obstructive Sleep Apnoea (OSA)
The Woolcock Institute of Medical Research0 sites193 target enrollmentMay 22, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Obstructive Sleep Apnoea
- Sponsor
- The Woolcock Institute of Medical Research
- Enrollment
- 193
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects have symptoms of sleep apnoea (including snoring, choking, witnessed apneas and daytime sleepiness) and/or co morbidities including obesity, hypertension and the metabolic syndrome.
Exclusion Criteria
- •Subjects are unable to comply with procedures, unable to apply the diagnostic device (either by patient or other care\-giver), or the diagnosis being considered is primarily a non\-OSA sleep disorder such as insomnia, parasomnia or narcolepsy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Primary care diagnostics or diagnostics in a memory clinic in older persons with memory complaints - A long-term cost-effectiveness trial with non-inferiority desigdementiamemory problems10012272NL-OMON53325Radboud Universitair Medisch Centrum294
Active, not recruiting
Not Applicable
Comparing dementia diagnostics in primary care and in memory clinics: which makes older patients fare better in the long term?Persons aged 70 years and older with memory complaintsMental and Behavioural DisordersISRCTN18043557Radboud University Nijmegen Medical Centre294
Recruiting
Phase 3
Improving the coverage of high priority health services in rural and tribal area of GujaratHealth Condition 1: R030- Elevated blood-pressure reading, without diagnosis of hypertensionHealth Condition 2: F99- Mental disorder, not otherwise specifiedHealth Condition 3: D578- Other sickle-cell disordersHealth Condition 4: E118- Type 2 diabetes mellitus with unspecified complicationsCTRI/2023/07/055643Bill and Melinda Gates Foundation
Active, not recruiting
Phase 1
Diagnostic efficacy and prognostic method [18F] DOPA-PET/CT instudy of neuroblastoma: comparison with 123I-MIBG scintigraphypatients wiht NB onset with high probability to return in stages 3 and 4 of the disease on the basis of the ultrasound images or TC. May also be included with the two-stage amplification of N-MYCMedDRA version: 14.1Level: PTClassification code 10029260Term: NeuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-005398-30-ITAZIENDA OSPEDALIERA OSPEDALI GALLIERA40
Recruiting
Not Applicable
Response evaluation after neoadjuvant chemotherapy for muscle invasive bladder cancerNL-OMON25664ot applicable180